Search Results - "Liu SV"

Probabilistic modeling of dietary arsenic exposure and dose and evaluation with 2003-2004 NHANES data.

Authors: Xue J Zartarian V Wang S et al.

Source: Environmental Health Perspectives. Mar2010, Vol. 118 Issue 3, p345-350. 6p.

URL: 48983366

Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315).

Authors: Mandl A Chen R Das S et al.

Source: The oncologist [Oncologist] 2026 May 08; Vol. 31 (6).

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study.

Authors: Skoulidis F Borghaei H Garon EB et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Nov 06; Vol. 17, pp. 17588359251386611. Date of Electronic Publication: 2025 Nov 06 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee.

Authors: McMahon RA Lee Min Chua K Faivre-Finn C et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Jun; Vol. 21 (6), pp. 103643. Date of Electronic Publication: 2026 Apr 04.

Publication Type: Journal Article; Consensus Statement; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy.

Authors: Radovich M Wacker J Solzak J et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 May 11; Vol. 75 (6). Date of Electronic Publication: 2026 May 11.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Authors: Besse B Subbiah V Curigliano G et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 May; Vol. 44 (13), pp. 1190-1197. Date of Electronic Publication: 2026 Mar 26.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

Authors: Trabolsi A Lekakis M Commisso PM et al.

Source: Cancers [Cancers (Basel)] 2026 Apr 28; Vol. 18 (9). Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Antibody-Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond.

Authors: Monaca F Gomez-Randulfe I Torres-Jiménez J et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Apr 14, pp. 103726. Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Authors: Gray JE Neal JW Patel JD et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Apr 10. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

A multi-taxon evaluation of tropical-subtropical boundary using tree-of-life eDNA across Taiwanese waters.

Authors: Peiris MAK Liu SV

Source: Marine environmental research [Mar Environ Res] 2026 Jul; Vol. 219, pp. 108095. Date of Electronic Publication: 2026 May 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9882895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0291 (Electronic) Linking ISSN: 01411136 NLM ISO Abbreviation: Mar Environ Res Subsets: MEDLINE

Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).

Authors: Raez LE Baca Y Ribeiro JR et al.

Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Jun; Vol. 25 (6), pp. 711-718. Date of Electronic Publication: 2025 Apr 17.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer.

Authors: Paz-Ares L Gupta B Baena J et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 168-178. Date of Electronic Publication: 2025 Mar 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.

Authors: Marks JA Ahn J Reuss JE et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 165-167. Date of Electronic Publication: 2024 Dec 04.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Oncogenic gene fusions in cancer: from biology to therapy.

Authors: Liu SV Nagasaka M Atz J et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 Apr 14; Vol. 10 (1), pp. 111. Date of Electronic Publication: 2025 Apr 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Authors: Waliany S Cooper AJ Liu SV et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Mar 16; Vol. 32 (6), pp. 1157-1168.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancer.

Authors: Marks JA Sweeney K Elliott A et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Mar; Vol. 213, pp. 108913. Date of Electronic Publication: 2026 Jan 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Authors: Puri S Elliott A Naqash AR et al.

Source: Cancer [Cancer] 2026 Mar 01; Vol. 132 (5), pp. e70284.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study.

Authors: Peters S Salomonsen RJ Diaz Perez I et al.

Source: ESMO open [ESMO Open] 2026 Jan; Vol. 11 (1), pp. 106031. Date of Electronic Publication: 2026 Jan 05.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

NRG1 Fusions: The New Kid on the Block.

Authors: Gupta B Borghaei L Liu SV

Source: Current oncology reports [Curr Oncol Rep] 2025 Feb; Vol. 27 (2), pp. 190-194. Date of Electronic Publication: 2025 Jan 31.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.

Authors: Grady CB Hwang WT Reuss JE et al.

Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Dec; Vol. 33 (12), pp. e70049.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE